{"url_path":"/sec/ostx/8-k/2026-07-02/item-3-02","section_key":"item-3-02","section_title":"Item 3.02 Unregistered Sales of Equity Securities.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-02","source_url":"https://www.sec.gov/Archives/edgar/data/1795091/0001213900-26-075013-index.html","accession_number":"0001213900-26-075013","cik":"0001795091","ticker":"OSTX","issuer_name":"OS Therapies Inc","edgar_url":"https://www.sec.gov/Archives/edgar/data/1795091/0001213900-26-075013-index.html","primary_entity_key":"0001795091","primary_entity_name":"OS Therapies Inc"},"word_count":87,"has_tables":true,"body_markdown":"** **\n\n**Item 3.02. Unregistered Sales of Equity Securities.**\n\n \n\nThe information contained\nin Item 1.01 of this Current Report on Form 8-K is hereby incorporated by reference into this Item 3.02. The Securities are being offered\nand sold by the Company in reliance upon an exemption from the registration requirements of the Securities Act of 1933, as amended (the\n“Securities Act”), afforded by Section 4(a)(2) thereof and/or Regulation D promulgated thereunder. The Investor represented\nthat it is an “accredited investor” as defined in Rule 501(a) under the Securities Act."}